8-K: Bausch + Lomb Completes Major Debt Refinancing, Securing New Notes and Upsized Credit Facilities

Bausch + Lomb announced the successful closing of a €675 million senior secured notes offering and a partial credit agreement refinancing, including a new $2.325 billion term loan and an $800 million revolving credit facility, aimed at repaying existing debt and enhancing financial flexibility.

Summary

• Bausch + Lomb's subsidiaries, Bausch & Lomb Incorporated and Bausch+Lomb Netherlands B.V., completed an upsized offering of €675 million aggregate principal amount of senior secured floating rate notes due 2031.
• The Notes bear interest at three-month EURIBOR (with a 0% floor) plus 3.875% per year, reset quarterly, and were sold at 99.500% of principal amount.
• The company also completed a partial refinancing of its credit agreement, entering into a Third Amendment to its existing credit agreement.
• The Third Amendment provides for a new $2.325 billion term B loan facility maturing in 2031 (New Term B Loans) and an $800 million revolving credit facility maturing in 2030 (New Revolving Credit Facility), which replaced the previous $500 million revolving commitments.
• The amortization rate for the New Term B Loans is 1.00% per annum, with the first installment payable on September 30, 2025.
• The initial interest rate for the New Term B Loans is 4.25% for SOFR Loans and 3.25% for ABR Loans; the rate for the New Revolving Credit Facility remains the same as the existing one.
• Net proceeds from the Notes offering and the New Term B Loans were used to repay in full the outstanding borrowings under the company's existing revolving credit facility, to refinance in full the outstanding term A loans due 2027 and term B loans due 2027, and to pay related fees and expenses.
• The Notes and their guarantees are senior secured obligations, ranking pari passu with existing and future unsubordinated indebtedness and effectively pari passu with existing and future first-priority lien indebtedness (including the credit facilities and the 2028 Notes).
• The Third Amendment includes modifications to certain negative covenant and other provisions of the credit agreement, designed to provide the company and its subsidiaries with increased flexibility, including adjusted financial covenant levels.

Sentiment

Score: 7

Explanation: The successful completion of an upsized debt offering and significant refinancing, extending maturities and increasing liquidity, is a positive financial management move. While a routine corporate finance event, the 'upsized' nature and increased flexibility are favorable, indicating market confidence and improved financial positioning.

Positives

• Successful completion of an upsized notes offering (€675 million) and a significant credit agreement refinancing ($2.325 billion term loan, $800 million revolving facility), indicating strong market access.
• Refinancing of existing debt (revolving credit facility, term A loans due 2027, term B loans due 2027) extends debt maturities to 2030 and 2031, improving the company's debt profile.
• The revolving credit facility was upsized from $500 million to $800 million, providing increased liquidity and financial flexibility.
• The Third Amendment includes increased financial covenant levels and other modifications, offering the company additional transaction flexibility.

Negatives

• The Notes were sold at a slight discount (99.500% of principal amount).
• The document does not explicitly state negative impacts, but the new interest rates and fees, while market-based, could represent a higher cost of debt depending on prevailing market conditions compared to the previous debt.

Risks

• Default in the payment of any principal or interest on the Notes or other indebtedness.
• Breach or default by the company or its Restricted Subsidiaries of certain covenants, including those related to financial metrics, restricted payments, investments, liens, fundamental changes, asset sales, and transactions with affiliates.
• Failure to comply with reporting requirements, if uncured for 120 days after written notice.
• Failure to pay final non-appealable judgments aggregating in excess of the greater of $150 million and 20.0% of LTM Consolidated Adjusted EBITDA.
• Any Note Guarantee by the Parent Guarantor or a Significant Subsidiary ceasing to be in full force and effect or being denied/disaffirmed.
• Liens with respect to all or substantially all of the Collateral ceasing to be valid or enforceable.
• Bankruptcy or insolvency proceedings against the company, any Issuer, any Restricted Subsidiary that is a Significant Subsidiary, or any group of Restricted Subsidiaries that, taken together, would constitute a Significant Subsidiary.
• Occurrence of a Change of Control, which could trigger a repurchase offer for the Notes at 101% of principal.
• Loan Document Obligations ceasing to constitute senior indebtedness under subordination provisions of other debt.
• Occurrence of ERISA Events or Canadian Pension Plan Termination Events that would reasonably be expected to result in a Material Adverse Effect.

Future Outlook

The document primarily details the terms of the debt instruments and refinancing. It states the proceeds will be used for general corporate purposes and to repay existing debt, but does not provide specific forward-looking financial guidance or strategic initiatives beyond the immediate refinancing.

Management Comments

• Bausch + Lomb announced that its subsidiaries... have closed the upsized offering...
• The company announced that it has completed a partial refinancing of its credit agreement...

Industry Context

This transaction represents a standard corporate finance activity for a publicly traded company. The successful execution of an upsized offering and significant refinancing indicates continued access to capital markets and market confidence in Bausch + Lomb, a leading global eye health company. The terms of the new debt reflect prevailing market conditions for secured floating rate notes and syndicated loans.

Comparison to Industry Standards

• The refinancing successfully extends debt maturities to 2030 and 2031, which is a common and positive financial management practice to reduce near-term refinancing risk.
• The upsized revolving credit facility from $500 million to $800 million provides increased liquidity, generally viewed as a positive indicator of financial health and operational flexibility.
• The adjustment of financial covenant levels, such as the maximum first lien net leverage ratio increasing from 4.50:1.00 to 5.75:1.00 (with step-downs), suggests a more flexible financial operating environment for the company, potentially aligning with current market practices or providing more headroom for strategic initiatives.
• The interest rates for the new debt instruments (EURIBOR + 3.875% for notes, SOFR/ABR + 4.25%/3.25% for term loans) are specific to this transaction and would require comparison to prevailing market rates for companies with similar credit profiles at the time of issuance to assess their competitiveness and alignment with industry benchmarks.

Corporate Governance

Related Party Transactions

• The document defines 'Affiliate Transaction' and sets limits for such transactions, requiring them to be on terms not substantially less favorable than arms-length transactions and, for larger transactions, requiring approval by disinterested board members.
• It references the 'Separation Transactions' and 'Separation Agreements' with Bausch Health Companies Inc., indicating ongoing or historical dealings with a related party.

Stakeholder Impact

• Shareholders: The refinancing extends debt maturities and increases liquidity, which generally reduces financial risk and could be positive for shareholder value by providing more stability and flexibility for future operations or capital allocation.
• Lenders/Noteholders: New lenders and noteholders are providing significant capital under new terms, while previous lenders whose debt was refinanced received repayment. The new terms define their rights, obligations, and security interests.
• Employees: A more stable financial position and increased flexibility can indirectly benefit employees by supporting business continuity and potential growth initiatives.
• Customers and Suppliers: No direct impact is specified, but a financially stable company is generally a more reliable partner for customers and suppliers.

Next Steps

• First installment payment for New Term B Loans on September 30, 2025.
• First interest payment for Notes on January 15, 2026.
• Ongoing compliance with new financial covenants and reporting requirements as detailed in the Indenture and Credit Agreement.
• Potential future optional redemptions of notes as per the terms outlined.

Key Dates

Recommendation

Keywords

Debt Refinancing, Senior Secured Notes, Floating Rate Notes, Term Loan Facility, Revolving Credit Facility, Bausch + Lomb, SEC Filing, Corporate Finance, EURIBOR, SOFR, Financial Covenants, Debt Maturity Extension, Capital Markets